Busra N. Unal

Umraniye, Turkey

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Variant reclassification in cancer susceptibility genes and an updated variant spectrum of Turkish breast and colorectal cancer patients.

Variant reclassification in cancer susceptibility genes and an updated variant spectrum of Turkish breast and colorectal cancer patients.

Journal: Human genomics

Published: October 17, 2025

Genetic heterogeneity in childhood leukemia/lymphoma: a Turkish cohort with strong predisposition.

Genetic heterogeneity in childhood leukemia/lymphoma: a Turkish cohort with strong predisposition.

Journal: Frontiers in genetics

Published: May 07, 2025

Clinical classification and molecular interpretation of germline pathogenic TP53 variations detected by multigene panel testing in patients with possible cancer predisposition.

Clinical classification and molecular interpretation of germline pathogenic TP53 variations detected by multigene panel testing in patients with possible cancer predisposition.

Journal: Molecular genetics and genomics : MGG

Published: December 27, 2024

Clinical management of three JMML siblings with germline CBL variation.

Clinical management of three JMML siblings with germline CBL variation.

Journal: Cancer genetics

Published: November 30, 2024

Molecular and In Silico Analysis of the CHEK2 Gene in Individuals with High Risk of Cancer Predisposition from Türkiye.

Molecular and In Silico Analysis of the CHEK2 Gene in Individuals with High Risk of Cancer Predisposition from Türkiye.

Journal: Cancers

Published: September 02, 2024

Managing CDH1 Cancer Risks in a Child: Complex Decision Making in a Family With Hereditary Diffuse Gastric Cancer.

Managing CDH1 Cancer Risks in a Child: Complex Decision Making in a Family With Hereditary Diffuse Gastric Cancer.

Journal: American journal of medical genetics. Part A

Published: April 18, 2024

Concurrent Pathogenic Variants of BRCA1, MUTYH and CHEK2 in a Hereditary Cancer Family.

Concurrent Pathogenic Variants of BRCA1, MUTYH and CHEK2 in a Hereditary Cancer Family.

Journal: Cancer genetics

Published: March 15, 2022

Immunohistochemical Evaluation of BAP1 Expression in Breast Cancer with Known BRCA1 and BRCA2 Mutations and Comparison with Histopathological Features.

Immunohistochemical Evaluation of BAP1 Expression in Breast Cancer with Known BRCA1 and BRCA2 Mutations and Comparison with Histopathological Features.

Journal: International journal of surgical pathology

Published: March 09, 2022

Determining the accuracy of next generation sequencing based copy number variation analysis in Hereditary Breast and Ovarian Cancer.

Determining the accuracy of next generation sequencing based copy number variation analysis in Hereditary Breast and Ovarian Cancer.

Journal: Expert review of molecular diagnostics

Published: March 04, 2022

Are nucleos(t)ide analogues effective against severe outcomes in COVID-19 and hepatitis B virus coinfection?

Are nucleos(t)ide analogues effective against severe outcomes in COVID-19 and hepatitis B virus coinfection?

Journal: Hepatology forum

Published: June 13, 2021

Clinical characteristics and risk factors associated with severe disease and outcome of patients with COVID-19.

Clinical characteristics and risk factors associated with severe disease and outcome of patients with COVID-19.

Journal: Journal of infection in developing countries

Published: May 31, 2021

Consistency of variant interpretations among bioinformaticians and clinical geneticists in hereditary cancer panels.

Consistency of variant interpretations among bioinformaticians and clinical geneticists in hereditary cancer panels.

Journal: European journal of human genetics : EJHG

Published: May 21, 2021

Showing 1-12 of 13

Last Updated: 09/26/2026